Stayble Therapeutics AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter, the company reported revenue was SEK 0.009 million compared to SEK 0.006 million a year ago. Net loss was SEK 4.56 million compared to SEK 1.09 million a year ago. Basic loss per share from continuing operations was SEK 0.33 compared to SEK 0.16 a year ago.
For the full year, revenue was SEK 0.009 million compared to SEK 0.078 million a year ago. Net loss was SEK 12.09 million compared to SEK 15.49 million a year ago. Basic loss per share from continuing operations was SEK 0.87 compared to SEK 2.24 a year ago.